Therefore, β2 microglobulin before chemotherapy, β2 microglobulin after chemotherapy, and lesion length after chemotherapy were selected as independent predictors of the CR after treatment in gastric DLBCL patients. The gene discussed is HLA-G; the disease is diffuse large B-cell lymphoma.